Refine by
Precision Dosing Articles & Analysis: Older
15 news found
Additionally, the technology eliminates the need for water and allows for discreet medication administration, enhancing patient convenience and privacy. Furthermore, the precise dosing potential of Oral Thin Films ensures accurate and consistent of medication delivery. ...
Micro-drug delivery systems utilize innovative technologies and materials to deliver precise medication doses to targeted body sites, improving efficacy and reducing side effects, especially in localized drug delivery therapies. ...
The system delivers the liquid methadone, and includes remote monitoring to make sure precise doses of medication are delivered. The $266,000 is for Phase I of the development of the system; Phase II would be for $1.7 million and would be contingent upon the assessment of Phase I, according to a Berkshire Biomedical July 25 announcement of the award. ...
COPA is a novel oral liquid dispensing system with remote monitoring and advanced analytics specifically designed to deliver accurate and precise doses of controlled and non-controlled prescription medications to only a biometrically authenticated Intended User. ...
The COPA is a novel, oral liquid dispensing system specifically designed to deliver accurate and precise doses of prescription medications only to a biometrically authenticated Intended User, with the goal of enhancing patient wellness by providing remote monitoring with advanced data analytics that are not dependent on patient self-reporting, allowing for ...
The presentation will highlight Berkshire’s Computerized Oral Prescription Administration System (COPA™), a novel oral liquid dispensing system specifically designed to deliver accurate and precise doses of controlled and non-controlled prescription medications to only a biometrically authenticated Intended User, with the goal of enhancing patient ...
This powerful duo provides faster and more precise targeted dose delivery to tumors thus further minimizing the damage to surrounding healthy tissue and organs at risk. The system also integrates a diagnostic CT imaging system and a surface tracking system for high precision patient positioning and intra-fraction motion management. ...
” ZetaMet™ works through a mechanism of action (MOA) which is a novel and patented molecular pathway. The small molecule, precisely-dosed, delivered to the affected area through a proprietary drug-eluting carrier, stimulates stem cells, activating cells to grow healthy bone known as “osteoblasts”, and inhibits cells associated with ...
The DermaPrecise Injector is an electronic injection system designed to offer new levels of control over any injection into the dermal and subcutaneous layers for which precision of depth, dose and/or delivery matters. The new provisional patent application, filed on November 11, 2021 covers new commercial embodiments of certain technologies related to its dermal ...
” ZetaMet™ works through a mechanism of action (MOA) which is a novel and patented molecular pathway. The small molecule, precisely-dosed, delivered to the affected area through a proprietary drug-eluting carrier, stimulates stem cells, activating cells to grow healthy bone known as “osteoblasts”, and inhibits cells associated with bone ...
Mevion Medical Systems is pleased to announce it has signed a contract with Kansas City Urology Care (KCUC) for the purchase of a MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning technology. Proton therapy is a precise form of radiation therapy that can reduce the amount of unnecessary radiation exposure to healthy tissue, which has the potential to ...
The results demonstrate that XTreo™ MF provides targeted, sustained and efficient dosing to local sinus tissues that is superior to intranasal corticosteroid sprays (INCS). ...
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has been awarded a grant from the Center for Advancing Point of Care Technologies (CAPCaT), a program run by the Massachusetts Medical Device Development Center (M2D2) funded by the National Heart, Lung, and Blood Institute and the National Center for Complementary and Integrative ...
Through the concentration of antibodies from plasma collected from recovered COVID-19 individuals, the hyperimmune globulin can offer precise and consistent dosing with high purity, high potency and a strong safety profile that may help current patients’ immune systems respond to the infection. ...
It is anticipated that the Epica’s open-architecture system will allow physicians to visualize target anatomy, plan surgical intervention and then excute the procedure with the surgeon’s preferred instruments all with robotic high-precision, lower dose and lower cost. Frank D. D’Amelio, CEO of Epica International, Inc., said, "I am very pleased ...